Targeting BRAF-mutant glioma: reflections on the ROAR trial.
Publication
, Journal Article
Peters, KB
Published in: Lancet Oncol
January 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
January 2022
Volume
23
Issue
1
Start / End Page
3 / 4
Location
England
Related Subject Headings
- Proto-Oncogene Proteins B-raf
- Oncology & Carcinogenesis
- Humans
- Glioma
- Brain Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B. (2022). Targeting BRAF-mutant glioma: reflections on the ROAR trial. Lancet Oncol, 23(1), 3–4. https://doi.org/10.1016/S1470-2045(21)00662-8
Peters, Katherine B. “Targeting BRAF-mutant glioma: reflections on the ROAR trial.” Lancet Oncol 23, no. 1 (January 2022): 3–4. https://doi.org/10.1016/S1470-2045(21)00662-8.
Peters KB. Targeting BRAF-mutant glioma: reflections on the ROAR trial. Lancet Oncol. 2022 Jan;23(1):3–4.
Peters, Katherine B. “Targeting BRAF-mutant glioma: reflections on the ROAR trial.” Lancet Oncol, vol. 23, no. 1, Jan. 2022, pp. 3–4. Pubmed, doi:10.1016/S1470-2045(21)00662-8.
Peters KB. Targeting BRAF-mutant glioma: reflections on the ROAR trial. Lancet Oncol. 2022 Jan;23(1):3–4.
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
January 2022
Volume
23
Issue
1
Start / End Page
3 / 4
Location
England
Related Subject Headings
- Proto-Oncogene Proteins B-raf
- Oncology & Carcinogenesis
- Humans
- Glioma
- Brain Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis